KRMD — Koru Medical Systems Cashflow Statement
0.000.00%
Last trade - 00:00- $258.02m
- $250.12m
- $33.65m
- 80
- 20
- 84
- 66
Annual cashflow statement for Koru Medical Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.21 | -4.56 | -8.66 | -13.7 | -6.07 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.92 | 2.71 | 3.29 | 2.81 | 2.88 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.93 | -1.11 | 1.4 | 1.2 | 1.97 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.743 | -4.32 | -5.4 | -4.89 | -0.32 |
| Capital Expenditures | -1.06 | -0.375 | -2.8 | -0.815 | -1.34 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.025 | 0.009 | 0 | — | 0.009 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -1.04 | -0.366 | -2.8 | -0.815 | -1.33 |
| Financing Cash Flow Items | 0 | 0.509 | -0.075 | -0.152 | -0.141 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 23.2 | 2.71 | 0.279 | -0.219 | -0.249 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.4 | -1.98 | -7.93 | -5.93 | -1.9 |